Sign in

PLSH on OTC

PANACEA LIFE SCIENCES HOLDINGS, INC.

PANACEA LIFE SCIENCES HOLDINGS, INC. is an American medicinal chemicals and botanical products company.1 It is headquartered in Greenwood Village, Colorado.1 Its shares trade on OTC under the symbol PLSH.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Target Group Inc., HEALTHY EXTRACTS INC. or TFA Therapeutics, Inc., or pick any stock.

  • TickerPLSH on OTC1
  • IndustryMedicinal Chemicals & Botanical Products1
  • HeadquartersGreenwood Village, Colorado1
  • Incorporated inNV2
  • Business address5910 South University Blvd, C18-193, Greenwood Village, Co 801212
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

October 2021, Panacea Life Sciences’ investment in the Cannabinoid Lab at Colorado State University (“CSU”) was realized.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

47.0%Gross margin4
-232.5%Operating margin4
-336.1%Net margin4
46.6%Revenue growth, 20234
-$1.6MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue45¢$1.3M
  • Interest55¢$1.6M

Out of $2.4M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$2.4M in 2023
0$2.5M$5.0M$7.5M$10.0M2017: $0$020172018: $0$020182019: $345.7K$345.7K20192020: $9.0M$9.0M2020+2509%2021: $2.1M$2.1M2021−77%2022: $1.6M$1.6M2022−21%2023: $2.4M$2.4M2023+47%
Gross profit67894$1.1M in 2023
-$2.0M-$1.0M0$1.0M$2.0M2018: $0$020182019: -$1.7M-$1.7M20192020: $2.0M$2.0M20202021: $540.6K$540.6K2021−73%2022: $396.5K$396.5K2022−27%2023: $1.1M$1.1M2023+183%
Operating income567894-$5.5M in 2023+77% since 2017
-$15.0M-$10.0M-$5.0M02017: -$3.1M-$3.1M20172018: -$2.4M-$2.4M2018−22%2019: -$10.7M-$10.7M2019+338%2020: -$5.3M-$5.3M2020−51%2021: -$5.9M-$5.9M2021+13%2022: -$5.7M-$5.7M2022−5%2023: -$5.5M-$5.5M2023−2%
Net income567894-$8.0M in 2023+108% since 2017
-$15.0M-$10.0M-$5.0M02017: -$3.9M-$3.9M20172018: -$4.3M-$4.3M2018+12%2019: -$10.0M-$10.0M2019+131%2020: -$5.2M-$5.2M2020−48%2021: -$4.8M-$4.8M2021−9%2022: -$9.1M-$9.1M2022+91%2023: -$8.0M-$8.0M2023−12%
Fiscal year2017201820192020202120222023
Revenue$05$06$345.7K7$9.0M8$2.1M9$1.6M4$2.4M4
Cost of revenue$06$1.9M7$7.0M8$1.5M9$1.2M4$1.3M4
Gross profit$06-$1.7M7$2.0M8$540.6K9$396.5K4$1.1M4
Research and development$356.1K5$300.0K6$22.1K7$07
Operating expenses$6.5M9$6.0M4$6.7M4
Operating income-$3.1M5-$2.4M6-$10.7M7-$5.3M8-$5.9M9-$5.7M4-$5.5M4
Interest$68.6K5$464.5K6$479.1K7$1.5M8$1.1M9$2.0M4$1.6M4
Income before tax-$4.8M9-$9.1M4-$8.0M4
Income tax$05$05
Net income-$3.9M5-$4.3M6-$10.0M7-$5.2M8-$4.8M9-$9.1M4-$8.0M4
Earnings per share-$0.289-$0.624-$0.484
Earnings per share (diluted)-$0.624-$0.484
Shares (weighted, basic)16.9M shares914.9M shares416.6M shares4
Shares (weighted, diluted)14.9M shares416.6M shares4

Compare PANACEA LIFE SCIENCES HOLDINGS, INC. with another company

Corporate structure

PANACEA LIFE SCIENCES HOLDINGS, INC. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of PANACEA LIFE SCIENCES HOLDINGS, INC.

  • Leslie Buttorff Filed SC 13D on PANACEA LIFE SCIENCES HOLDINGS, INC., latest Jun 23, 2023
  • Harvey J. Kesner Filed SC 13D/A on PANACEA LIFE SCIENCES HOLDINGS, INC., latest Apr 5, 2022
  • PANACEA LIFE SCIENCES HOLDINGS, INC. Greenwood Village, Colorado

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What PANACEA LIFE SCIENCES HOLDINGS, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$13.7M4 Dec 31, 2023$13.2M4 Dec 31, 2022+3.7%
Accumulated depreciation$7.2M4 Dec 31, 2023$5.5M4 Dec 31, 2022+31.0%
Property and equipment, net$6.4M4 Dec 31, 2023$7.7M4 Dec 31, 2022−16.0%
Operating-lease assets (leased space)$3.9M4 Dec 31, 2023$3.2M4 Dec 31, 2022+19.2%

Real estate and locations

ItemLatestA year beforeChange
Area of land51,000 sq ft4 Dec 31, 2023

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$100.9K4 Dec 31, 2023$7.0K4 Dec 31, 2022+1351.9%
Marketable securities, current$14.9K4 Dec 31, 2023$1.1M4 Dec 31, 2022−98.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$3.0M4 Dec 31, 2023$2.2M4 Dec 31, 2022+37.7%
Intangible assets, net (excluding goodwill)$3.0M4 Dec 31, 2023$2.2M4 Dec 31, 2022+37.7%
Finite-lived intangibles, gross$307.0K9 Dec 31, 2022$307.0K9 Dec 31, 20210%
Accumulated amortization-$307.0K9 Dec 31, 2022-$245.6K9 Dec 31, 2021−25.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$4.0M4 Dec 31, 2023$4.4M4 Dec 31, 2022−9.8%
Work in process$1.9M4 Dec 31, 2023$1.9M4 Dec 31, 2022+0.4%
Finished goods$1.3M4 Dec 31, 2023$1.7M4 Dec 31, 2022−25.5%

Leadership

Who has led PANACEA LIFE SCIENCES HOLDINGS, INC., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Philip J. Young2017–2018
  2. Emiliano Angel Aloi2019
  3. Leslie Buttorff2021–2023

President

  1. Philip J. Young2017–2018
  2. Emiliano Angel Aloi2019

Chief financial officer

  1. Kelley A. Wendt2017
  2. Ken Puzder2020

Chief operating officer

  1. Alvaro Daniel Alberttis2021
20202025
Board members and other officers (18)

Former names

  • Exactus, Inc.Mar 28, 2016 to Oct 26, 20212
  • Spiral Energy Tech., Inc.Sep 12, 2012 to Mar 4, 20162
  • Solid Solar Energy, Inc.Aug 16, 2012 to Aug 7, 20132

Timeline

  1. May 16, 20248-K Entered a material agreement; Other events36
  2. May 7, 20248-K Change of auditor37
  3. Mar 7, 20248-K Entered a material agreement; New debt or obligation38
  4. Feb 5, 20248-K Entered a material agreement39
  5. Dec 8, 20238-K Completed an acquisition or sale40
  6. Oct 5, 20238-K Entered a material agreement; Completed an acquisition or sale; Unregistered sale of shares41
  7. Oct 2, 20238-K Entered a material agreement; Other events42
  8. Jul 10, 20238-K Entered a material agreement; Regulation FD disclosure43
  9. Jun 2, 20238-K Executive or director change44
  10. Feb 14, 20238-K Entered a material agreement; New debt or obligation45
  11. Jan 23, 20238-K Other events46
  12. Dec 27, 20228-K Entered a material agreement; New debt or obligation47
  13. Jul 2, 2021New chief executive Leslie Buttorff becomes CEO13
  14. Oct 7, 2019New chief executive Emiliano Angel Aloi becomes CEO14
  15. Aug 18, 2017New chief executive Philip J. Young becomes CEO15

Filings

71 filings to the SEC since October 2021: 6 annual reports, 12 quarterly reports, 23 major events, 16 insider forms, 2 large holders, 12 other. The latest 20:

  1. May 9, 2025SEC STAFF ACTION EDGAR
  2. Jul 16, 202415-12G EDGAR
  3. Jun 11, 20241-A EDGAR
  4. May 16, 20248-K EDGAR
  5. May 7, 20248-K EDGAR
  6. May 6, 202410-Q EDGAR
  7. Apr 1, 202410-K EDGAR
  8. Mar 7, 20248-K EDGAR
  9. Feb 5, 20248-K EDGAR
  10. Dec 8, 20238-K/A EDGAR
  11. Nov 14, 202310-Q EDGAR
  12. Oct 5, 20238-K EDGAR
  13. Oct 2, 20238-K EDGAR
  14. Sep 20, 20234 EDGAR
  15. Aug 15, 202310-Q EDGAR
  16. Aug 15, 2023NT 10-Q EDGAR
  17. Jul 10, 20238-K EDGAR
  18. Jun 23, 2023SC 13D EDGAR
  19. Jun 12, 20234 EDGAR
  20. Jun 2, 20238-K EDGAR

The 71 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

50 open-market trades by officers, directors and large owners since October 2021: 50 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 18, 2023Buttorff LeslieCEOBuy20,000$0.24$4.8KForm 4
Jun 9, 2023Buttorff LeslieCEOBuy3,000$0.43$1.3KForm 4
May 23, 2023Buttorff LeslieCEOBuy500$0.50$250Form 4
May 19, 2023Buttorff LeslieCEOBuy6,000$0.51$3.1KForm 4
May 9, 2023Buttorff LeslieCEOBuy2,300$0.38$874Form 4
May 8, 2023Buttorff LeslieCEOBuy1,500$0.43$645Form 4
May 5, 2023Buttorff LeslieCEOBuy11,500$0.49$5.6KForm 4
Apr 26, 2023Buttorff LeslieCEOBuy5,500$0.40$2.2KForm 4
Apr 25, 2023Buttorff LeslieCEOBuy4,500$0.37$1.6KForm 4
Apr 5, 2023Buttorff LeslieCEOBuy2,500$0.33$825Form 4
Apr 4, 2023Buttorff LeslieCEOBuy3,200$0.35$1.1KForm 4
Apr 3, 2023Buttorff LeslieCEOBuy1,000$0.36$360Form 4
Feb 27, 2023Buttorff LeslieCEOBuy3,000$0.18$530Form 4
Feb 26, 2023Buttorff LeslieCEOBuy1,000$0.19$190Form 4
Dec 1, 2022Buttorff LeslieCEOBuy1,000$0.10$100Form 4
Nov 29, 2022Buttorff LeslieCEOBuy2,000$0.13$260Form 4
Nov 23, 2022Buttorff LeslieCEOBuy3,000$0.10$300Form 4
Sep 13, 2022Buttorff LeslieCEOBuy1,000$0.10$100Form 4
Aug 26, 2022Buttorff LeslieCEOBuy15,000$0.14$2.1KForm 4
Aug 19, 2022Buttorff LeslieCEOBuy6,500$0.16$1.0KForm 4

All 50 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How PANACEA LIFE SCIENCES HOLDINGS, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARPANACEA LIFE SCIENCES HOLDINGS, INC.1
  • CIK0001552189
  • Employer ID (EIN)27-10858581
  • Filer status<br>emerging growth company1
  • Incorporated inNevada1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2833 Medicinal Chemicals & Botanical Products1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address5910 South University Blvd, C18-193, Greenwood Village, CO 801211
  • Phone561-455-48221
  • Shares outstanding17,645,352 as of May 1, 202412
  • Public float$3.5M as of Jun 30, 20224
  • On EDGAR sinceAug 16, 20121
  • Filings316 in all: 8-K (117), 4 (37), 10-Q (27), 3 (23), NT 10-Q (12), 10-K (9), CORRESP (9), UPLOAD (9)1
    All 35 form types

    D (8), S-1/A (8), 10-Q/A (6), SC 13D (6), 8-K/A (5), SC 13D/A (5), 10-K/A (4), 5 (3), DEF 14C (3), PRE 14C (3), S-1 (3), 4/A (2), NT 10-K (2), SEC STAFF ACTION (2), 1-A (1), 144 (1), 15-12G (1), 3/A (1), 424B3 (1), 424B4 (1), 8-A12B (1), 8-A12G (1), CT ORDER (1), EFFECT (1), RW (1), S-8 (1), SC 13G (1)

  • Latest filingsAnnual report (10-K) Apr 1, 2024
    Quarterly report (10-Q) May 6, 2024
    Latest 8-K (8-K) May 16, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
    SEC EDGAROther events
  47. 47
  48. 48
  49. 49